| Literature DB >> 35619818 |
Amy L Hall1, Paul A Demers2, Linda VanTil1, Mary Beth MacLean3, Maria E Dalton4, Trish Batchelor5, Lesley Rushton6, Tim R Driscoll7.
Abstract
Presumptive condition lists formally accept connections between military factors and veteran health conditions. An environmental scan of such lists and their evidentiary basis was conducted across four veterans' administrations to inform other administrations considering the development of such lists. Information on included conditions, qualifying military factors, and scientific processes was obtained through targeted internet searches and correspondence with veterans' administrations. The content of presumptive condition lists across jurisdictions varied by conditions included, as well as military eligibility requirements (e.g., service in particular conflict, context, or time period). Scientific review processes to develop lists also varied across jurisdictions. Findings indicate that evidence and experience may be leveraged across compensation systems (veteran and civilian). Ongoing research to understand links between military exposures and veteran health is recommended.Entities:
Keywords: occupational compensation; scientific review; veteran affairs; veteran benefits; veteran health; veteran health administration
Mesh:
Year: 2022 PMID: 35619818 PMCID: PMC9127463 DOI: 10.3389/fpubh.2022.739746
Source DB: PubMed Journal: Front Public Health ISSN: 2296-2565
Included conditions and exposure criteria for veterans, The United States of America (5, 11).
|
|
|
|---|---|
| Anemia, primary; Arteriosclerosis; Arthritis; Atrophy, Progressive muscular; Brain hemorrhage; Brain thrombosis; Bronchiectasis; Calculi of the kidney, bladder, or gallbladder. Cardiovascular-renal disease including hypertension; Cirrhosis of the liver; Coccidioidomycosis; Diabetes mellitus; Encephalitis lethargica residuals; Endocarditis; Endocrinopathies; Epilepsies; Hansen's disease; Hodgkin's disease; Leukemia; Lupus erythematosus, systemic; Myasthenia gravis; Myelitis; Myocarditis; Nephritis; Other organic nervous system diseases; Paget's disease; Osteomalacia; Palsy, bulbar; Paralysis agitans; Psychoses; Purpura idiopathic, hemorrhagic; Raynaud's disease; Sarcoidosis; Scleroderma; Sclerosis, amyotrophic lateral or multiple; Syringomyelia; Thromboangiitis obliterans; Tuberculosis, active; Tumors, malignant, or of brain, spinal cord or peripheral nerves; Ulcers, peptic (gastric or duodenal). | Condition becomes manifest within 1 year (within 3 years for Hansen's disease and tuberculosis; within 7 years for multiple sclerosis) from the date of separation from service. |
| Amebiasis; Blackwater fever; Cholera; Dracontiasis; Dysentery; Filariasis; Leishmaniasis; Loiasis; Malaria; Onchocerciasis; Oroya fever; Pinta; Plague; Schistosomiasis; Yaws; Yellow fever; Resultant disorders or diseases originating from therapy administered in connection with such diseases or as a preventative. | Tropical service. |
| Avitaminosis; Beriberi (including beriberi heart disease); Chronic dysentery; Helminthiasis; Malnutrition (including associated optic atrophy); Pellagra; Other nutritional deficiencies; Irritable bowel syndrome | Former prisoner of war, imprisoned for at least 30 days. |
| Any of the anxiety states; Psychosis; Dysthymic disorder; Stroke and its complications; Cirrhosis of the liver; Atherosclerotic heart disease or hypertensive vascular disease and their complications; Organic residual of frostbite or trench foot; Post-traumatic osteoarthritis; Osteoporosis (specified circumstances). | Former prisoner of war, imprisoned for any length of time. |
| AL amyloidosis; Chloracne or other acneform; Type 2 diabetes; Hodgkin's disease; Ischemic heart disease; All chronic B-cell leukemias; Multiple myeloma; Non-Hodgkin's lymphoma; Parkinson's disease; Early-onset peripheral neuropathy; Porphyria cutanea tarda; Prostate cancer; Respiratory cancers (cancer of the lung, bronchus, larynx, or trachea); Soft-tissue sarcoma (other than osteosarcoma, chondrosarcoma, Kaposi's sarcoma, or mesothelioma). | Exposure to an herbicide agent during active military, naval, or air service; including service in the Vietnam War in the Republic of Vietnam between January 9, 1962, and May 7, 1975. |
| Multiple Myeloma, All forms of leukemia (other than chronic lymphocytic leukemia); lymphomas (except Hodgkin's disease); Primary liver cancer (except if cirrhosis or hepatitis B is indicated); Bronchiolo-alveolar carcinoma; Cancer of the bile ducts, brain, breast, bone, colon, lung, gall bladder, esophagus, ovaries, pancreas, pharynx, salivary gland, small intestine, stomach, thyroid, or urinary tract (including kidneys, renal pelves, ureters, urinary bladder, and urethra). | Veterans who participated in a “radiation-risk” activity: Onsite participation in a test involving atmospheric detonation of a nuclear device; Occupation of Hiroshima or Nagasaki, Japan, between August 6, 1945, and July 1, 1946; Internment as prisoner of war in Japan (or service in Japan following internment) in WW2; Service before Feb 1, 1992 at specified US gaseous diffusion plants; Service before January 1, 1974 on Amchitka Island, Alaska; Qualification as “Special Exposure Cohort” member. |
| Cancer of the kidney, liver, or bladder; Non-Hodgkin's lymphoma; Adult leukemia; Multiple Myeloma; Parkinson's Disease; Aplastic anemia and other myelodysplastic syndromes. | Exposure to contaminants in the water supply at Camp Lejeune during service. |
| Gulf War Veterans who: | |
| Medically unexplained chronic multi-symptom illnesses that exist for 6 months or more, such as Chronic fatigue syndrome, Fibromyalgia, Irritable bowel syndrome; Any diagnosed or undiagnosed illness that warrants a presumption of service connection, as determined by the Secretary of Veterans Affairs | Served in the Southwest Asia Theater of Operations and have a condition that is at least 10% disabling by December 31, 2026 |
| Brucellosis; Campylobacter jejuni; Coxiella burnetii (Q fever); Non-typhoid Salmonella; Shigella; West Nile virus; Malaria (or when accepted treatises indicate the incubation period began during a qualifying period of service); mycobacterium tuberculosis; visceral leishmaniasis | Served in the Southwest Asia Theater of Operations or in Afghanistan on or after September 19, 2001 and manifest one of the following infectious diseases to a degree of 10% or more within 1 year of separation (note: mycobacterium tuberculosis and visceral leishmaniasis covered at any time after separation) |
| Asthma; rhinitis; sinusitis, to include rhinosinusitis | Served any length of time in the Southwest Theater of Operations during the Persian Gulf War, or any length of time in Afghanistan, Syria, Djibouti or Uzbekistan on or after September 19, 2001, and manifests condition to any degree within 10 years of separation from military service |
Abbreviated list and criteria; see references for full details on conditions and exposure criteria.
Included conditions and exposure criteria for veterans, New Zealand (9).
|
|
|
|---|---|
| AL-type primary amyloidosis; Chloracne; Type 2 diabetes; Ischaemic heart disease; Hodgkin's disease; Hypertension; Non-Hodgkin's lymphoma; Chronic lymphocytic leukemia (including hairy-cell leukemia and other chronic B-cell leukaemias); Multiple Myeloma; Acute and subacute peripheral neuropathy; Parkinson's disease; Porphyria cutanea tarda; Prostate cancer; Respiratory cancers of the lung, bronchus, larynx, trachea; Soft-tissue sarcoma; Stroke | Served in Vietnam between May 29 1964 and March 1975 |
| All forms of leukemia (except chronic lymphocytic leukemia); Lymphomas (other than Hodgkin's lymphomas); Multiple Myeloma; Primary liver cancer (except if cirrhosis or hepatitis B is indicated); Bronchioloalveolar carcinoma; Cancer of the bile ducts, brain, breast, bone, colon, lung, gall bladder, esophagus, ovary, pancreas, pharynx, salivary gland, small intestine, stomach, thyroid, or urinary tract (renal, ureter, urinary bladder, or urethra) | Exposed to nuclear radiation |
| Chronic fatigue syndrome; Fibromyalgia; Irritable bowel syndrome | Served in the Gulf Conflict between December 20 1990 and April 13 1991 |
| Any of the anxiety states; Beriberi; Chronic dysentery; Cirrhosis of the liver; Dysthymia; Heart disease or hypertensive vascular disease and their complications; Helminthiasis (intestinal vermiform parasites); Hypovitaminosis; Irritable bowel syndrome; Malnutrition (including optic atrophy); Organic residual of frostbite or trench foot; Pellagra and/or other nutritional deficiencies; Peptic ulcer disease; Peripheral neuropathy; Post-traumatic osteoarthritis; Psychosis; Stroke and residuals of stroke. | Prisoner of war, for any length of time, during the Second World War |
Service as part of the British Occupation Force of Japan between 1946 and 1952 (J Force), or on HMNZS Pukaki from May 15, 1957 to November 8, 1957, HMNZS Pukaki from April 28, 1958 to September 23, 1958, HMNZS Otago on July 22, 1973, HMNZS Canterbury on July 28, 1973, HMNZS Rotoiti as part of Operation Grapple from May 15, 1957 to November 8, 1957.
Included conditions and exposure criteria for veterans, The United Kingdom (6, 7).
|
|
|
|---|---|
| Mesothelioma | Royal Navy service of any duration on seagoing ships between 1939 and 1973 |
| Leukaemias (other than chronic lymphatic leukemia) | Participation at the tests or experimental programmes without case-specific dose determination, when presenting clinically within 25 years of presence at the tests or weapons experiments |
Included conditions and exposure criteria for Veterans, Australia (8).
|
| |
|---|---|
|
| |
| Non-melanotic malignant neoplasm of the skin; Malignant melanoma of the skin or eye; Acquired cataract; Benign neoplasm of the eye and adnexa; Malignant neoplasm of the eye; Non-melanotic malignant neoplasm of the skin; Pinguecula; Pterygium; Seborrheic keratosis; Solar keratosis | Sunlight or ultraviolet light exposure, various cumulative hours and geographic areas |
| Achilles tendonitis or bursitis; Chondromalacia patella; Femoroacetabular impingement syndrome; Iliotibial band syndrome; Patellar tendinopathy; Plantar fasciitis; Shin splints; Trochanteric bursitis and gluteal tendinopathy; Patellar tendinopathy | Weight bearing exercise involving repeated activity, various intensities |
| Acute articular cartilage tear; Acute meniscal tear of the knee; Labral tear; Sprain and strain; Dislocation of a joint; Cut, stab, abrasion and laceration; Fracture; Joint instability; External bruise; Internal derangement of the knee | Significant physical force or physical trauma applied to or through affected area |
| Physical injury due to munitions discharge | Munitions discharge |
| Sensory neural hearing loss; Tinnitus | Sound exposure of at least 140 dB(C) |
| External burn | Heat source, extreme cold, corrosive chemicals, radiation |
| Tinea | Exposed to the tinea dermatophyte; skin maceration; other |
|
| |
| Intervertebral disc prolapse; Lumbar spondylosis; Osteoarthritis (lower limb); Thoracic spondylosis | Lifting loads, various cumulative load-factors |
| Rotator cuff syndrome | Repetitive or sustained activities of the affected shoulder |
| Post-Traumatic Stress Disorder (PTSD); Anxiety disorder; Adjustment disorder | Hostile or life threatening environment for at least 4 weeks, various onset timeframes |
Abbreviated; see full summary of factors required to connect conditions with military service via (.